Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03842384 · ClinicalTrials.gov registry record · NA
Digital Health Intervention to Support Opioid Use Disorder Treatment
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03842384 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 80 participants.
The verdict
NCT03842384, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
In prior studies, the investigative team developed a combined computer- and text message-delivered personalized-feedback intervention (iENDURE) designed to enhance motivation and improve tolerance of distress to support the early phase of buprenorphine treatment. Specific aims of this subsequent study include conducting a preliminary randomized controlled trial with 80 participants to examine the efficacy of iENDURE relative to Treatment-as-Usual (TAU).
Interventions
- BEHAVIORAL iENDURE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2023-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03842384
The ClinicalTrials.gov registry entry for NCT03842384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iENDURE is the first listed.
NCT03842384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03842384 about?
NCT03842384 is a clinical study titled "Digital Health Intervention to Support Opioid Use Disorder Treatment". In prior studies, the investigative team developed a combined computer- and text message-delivered personalized-feedback intervention (iENDURE) designed to enhance motivation and improve tolerance of distress to support the early phase of buprenorphine treatment. Specific aims of this subsequent stu...
What is the current status of trial NCT03842384?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2020-10-01. Estimated completion is 2023-11-15.
What interventions are being tested in trial NCT03842384?
The interventions under investigation include: iENDURE (BEHAVIORAL).
Who is sponsoring clinical trial NCT03842384?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.